Review
Open access
Jul 2026
Recent Progress in Targeting Kinases Involved in the DNA Damage Response for the Treatment of Cancer
The current ATM, ATR, DNA-PK, CHK1, CHK2 and WEE1 inhibitors that show the most promise as monotherapies and combination treatments in solid tumours are discussed, as well as the potential benefits of using TPD technology over small-molecule inhibitors.
Lauryn Buckley-Benbow, Antonia M. Rout, Andrew B. Fielding et al.
· TARGETS · 0 citations